Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patients

doi:10.3748/wjg.v23.i15.2802

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 15

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8326)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

581

WORD

290

HTML

4008

Figures (1-5)

278

Tables (1-3)

234

Sum=5391

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

958

Download

1977

Sum=2935

Apr 21, 2017 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Apr 21, 2017; 23(15): 2802-2810
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2802

Full Size Figure Download Figure

Figure 4 Percentages of liver biopsies with marked necroinflammation and fibrosis categorized by age. A: Percentages of marked necroinflammation in different age groups; B: Percentages of marked fibrosis in different age groups. HBeAg: Hepatitis e antigen.

Citation: Cheng JL, Wang XL, Yang SG, Zhao H, Wu JJ, Li LJ. Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patients. World J Gastroenterol 2017; 23(15): 2802-2810
URL: https://www.wjgnet.com/1007-9327/full/v23/i15/2802.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i15.2802